MAY
4
Back by Popular Demand - KRAS G12C Mutation: An Emerging Biomarker for NSCLC Sponsored by Amgen®
5
Combating COVID-19 – Monoclonal Antibody Therapies to Optimize Patient Care: HHS/ASPR COVID-19 Therapeutics program
6
Myasthenia Gravis: How antibody testing helps you in the management of your patient
Give Us Your Feedback
Presentation: Facioscapulohumeral Muscular Dystrophy (FSHD) Clinical Overview and Testing Methodologies
Publication: Frequency of frontotemporal dementia gene variants in C9ORF72, MAPT, and GRN in academic versus commercial laboratory cohorts